Colgate-Palmolive Company: EPS $0.97 vs $0.926 expected; revenue $5.37B vs $5.34B
Key Facts
Q3 FY2026 results
| Metric | Actual | Estimate | Surprise | Year ago |
|---|---|---|---|---|
| EPS (USD) | 0.970 | 0.926 | +4.8% | 0.910 |
| Revenue (USD bn) | 5.370 | 5.340 | +0.6% | 5.130 |
Recent reports: actual vs estimate
| Reported | Period | EPS (USD) | Estimate | Surprise | Revenue (USD bn) | Estimate | Surprise |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Q3 FY2026 | 0.97 | 0.926 | +4.8% | 5.37 | 5.34 | +0.6% |
| Jul 31, 2026 | Q2 FY2026 | 0.99 | 0.947 | +4.5% | 5.36 | 5.36 | +0.1% |
| May 1, 2026 | Q1 FY2026 | 0.97 | 0.943 | +2.9% | 5.32 | 5.22 | +2.1% |
| Jan 30, 2026 | Q4 FY2025 | 0.95 | 0.912 | +4.2% | 5.23 | 5.12 | +2.1% |
| Oct 31, 2025 | Q3 FY2025 | 0.91 | 0.889 | +2.4% | 5.13 | 5.13 | +0.1% |
| Aug 1, 2025 | Q2 FY2025 | 0.92 | 0.897 | +2.6% | 5.11 | 5.04 | +1.5% |
| Apr 25, 2025 | Q1 FY2025 | 0.91 | 0.856 | +6.3% | 4.91 | 4.87 | +0.9% |
| Jan 31, 2025 | Q4 FY2024 | 0.91 | 0.900 | +1.1% | 4.95 | 4.98 | −0.7% |
Source: Figures from the EL7 database. Estimates are the analyst consensus carried by our data vendor (FMP), not official figures.
Colgate-Palmolive Company results: EPS $0.97 vs $0.926 expected; revenue $5.37B vs $5.34B. The results cover the company's Q3 FY2026. EPS came in above analysts' estimate by 4.8%; revenue above the estimate by 0.6%.
Revenue was up 4.6% from $5.13 billion a year earlier (Q3 FY2025). EPS was up 6.6% from $0.91 a year earlier. On its record, EPS topped analysts' estimates in 7 of 7 earlier comparable reports.
What the results mean
The results reflect sales growth at Colgate-Palmolive Company, but the available material does not identify the contributions from pricing, volumes or product mix. The business rests on everyday care products and pet nutrition, making the sources of demand central to understanding operating performance.
Business drivers include the distribution of oral, personal and home care products through retailers, distributors and online channels. Pet nutrition adds specialized foods and therapeutic diets, making product mix and distribution channels central to understanding sales and profitability.
What to watch on the earnings call: The earnings call merits attention for management's explanation of sales growth, the roles of pricing, volumes and product mix, and how demand varies across care products and pet nutrition. Commentary on margins, spending, and the roles of stores and online channels in reaching consumers also deserves attention.
For the full analysis of Colgate-Palmolive Company stock — valuation, scores and financial statements — see the stock page linked with this story.